LNTH Stock Analysis: Buy, Sell, or Hold?
LNTH - Lantheus Holdings, Inc
$109.89
0.93 (0.85%)
▲
5d:
+0.81%
30d:
+14.11%
90d:
+45.17%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LNTH trades at premium valuation expecting 9.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: LNTH trades at premium valuation expecting 9.1% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$147.00
Based on 11.9% avg growth
INTRINSIC VALUE TODAY
$91.28
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $109.89, which is considered extended relative to its 30-day fair value range of $99.44 to $107.72. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.2) compared to its historical average (13.2). At these levels, the market is pricing in 9.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is approaching resistance at $111.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (7th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is approaching resistance at $111.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (7th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$99.44 -
$107.72
Company Quality Score
63/100
(BUY)
Options IV Signal
7th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
55.8%
Protect Your Profits
Holding LNTH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 7th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($105.23)
- NEUTRAL: Trading at premium valuation - market expects 9.1% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$99.44 -
$107.72
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$7.68
(7.0%)
Support & Resistance Levels
Support Level
$102.97
Resistance Level
$111.86
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.20
Wall Street Target
$105.23
(-4.2%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
76.5%
Profit Margin
18.1%
Valuation Premium vs History
+9.1% premium
PE vs Historical
17.2 vs 13.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.1%
(market-implied from PE analysis)
1-Year Target
$119.89
(+9%)
2-Year Target
$130.80
(+19%)
3-Year Target
$142.70
(+30%)
3-Yr Target (if PE normalizes)
(PE: 17→13)
PE COMPRESSION
$109.49
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 19.8%)
$238.97
(+118%)
Base:
(SPY PE: 17.2, Growth: 19.8%)
$188.77
(+72%)
Bear:
(PE: 13.2, Growth: 19.8%)
$144.83
(+32%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 26.00 | Current EPS (TTM): $4.19
Bull Case
$182.71
(+66%)
Analyst growth 52.4%, PE expands to 28.6
Base Case
$166.10
(+51%)
Market implied 52.4%, PE stable at 26.0
Bear Case
$74.09
(-33%)
Severe decline -20.0%, PE contracts to 22.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 4:34 PM ET
Data refreshes hourly during market hours. Next update: 5:34 PM
Data refreshes hourly during market hours. Next update: 5:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 56 HOLD |
Advanced LNTH Option Strategies
Professional options setups generated by AI based on today's LNTH price and gamma walls.
